Clinical Trials Browser

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

Phase 4 Active not recruiting

92 enrolled

Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01824537 2025-03-19

TRAP-HPV

Phase 4 Completed

372 enrolled 12 charts

Papillomavirus Infections

NCT05202860 2025-01-22

VAXAK

Phase 2 Active not recruiting

70 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratosis, Actinic

NCT06686043 2024-11-13

HPV-VIM

Phase 2 Recruiting

85 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

NCT03489707 2024-11-12

The Prevent Anal Cancer Self-Swab Study

Phase NA Completed

253 enrolled 10 charts

Gastrointestinal

Anus Neoplasms

NCT04774887 2024-02-23

ERADICATING CERVICAL CANCER IN KENYA

Phase NA Completed

300 enrolled

HIV Infections

NCT02865135 2024-01-11

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Phase 1/2 Completed

11 enrolled 18 charts

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT05173324 2022-08-03

H2VICTORY

Phase 3 Not yet recruiting

8,000 enrolled

HIV Infections, Papillomavirus Infections

NCT01928225 2020-06-24

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Phase 2 Completed

180 enrolled 11 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01735006 2020-02-24

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Phase 3 Completed

7,372 enrolled

Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Phase 2 Completed

1,600 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01096134 2015-10-12

MDI

Phase NA Completed

8,000 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00501137 2015-04-10

BCGov-01

Phase 3 Completed

830 enrolled

Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT01034358 2012-10-23

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Phase 4 Completed

15 enrolled 6 charts

Gynecologic

Uterine Cervical Dysplasia, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

NCT01133509 2012-08-23

A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study

Phase NA Unknown

100 enrolled

Genital Human Papilloma Virus Infection

Clinical Trials

Intradermal, Fractional Dose of HPV Vaccines:

Immunogenicity of Fractional Dose of the HPV Vaccines

AGO-Gard

TRAP-HPV

VAXAK

HPV-VIM

The Prevent Anal Cancer Self-Swab Study

ERADICATING CERVICAL CANCER IN KENYA

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

H2VICTORY

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

MDI

BCGov-01

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study